XCX.CN stock rose 100.00% to C$0.01 on CNQ during market hours on 03 Mar 2026, making Greenrise Global Brands Inc. one of today’s top gainers. The move followed very low average volume and a small trade block; the stock opened at C$0.01 after a previous close of C$0.005. Investors should note the tiny market cap of C$516,554.00 and the company’s negative EPS of -0.03, which frame this rally as short-term price action rather than fundamental recovery.

XCX.CN stock: intraday price action and volume

XCX.CN stock traded at C$0.01 with volume of 1,465 shares versus an average volume of 33,354.00, showing low liquidity and a large relative move. The one-day change was +0.005 or 100.00%, with a day high and low both recorded at C$0.01. Low float and a trade cluster can drive sharp intraday swings in microcaps.

Drivers and company context for Greenrise Global Brands Inc.

Greenrise Global Brands Inc. (XCX.CN) is a Vancouver-based healthcare supplier of EU-GMP medical and cosmetic cannabis products in Germany. Recent headlines are limited; small trades, sector chatter and microcap re-ratings often explain sudden gains for names with thin trading. The company lists its website at Greenrise Global.

Financials, valuation and risk snapshot

The company shows negative earnings with EPS -0.03 and a negative PE of -0.33, reflecting losses. Key metrics show book value per share of -0.09 and a current ratio close to 0.00, indicating strained liquidity. The formal company rating dated 2026-02-17 is D+ (Strong Sell) across DCF and ROE metrics, highlighting high fundamental risk.

Technicals, sector context and trading setup

Technicals show RSI 59.81 and ADX 40.34, suggesting recent momentum on a very narrow price range. Price averages are 50-day C$0.01 and 200-day C$0.01, so relative strength is largely volume-driven. In the Healthcare sector, average peers show higher PE and stronger liquidity, placing XCX.CN outside typical sector norms.

Meyka AI rates XCX.CN with a score out of 100

Meyka AI rates XCX.CN with a score out of 100: 64.90 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company grade coexists with a separate company rating of D+ (Strong Sell), underscoring divergence between short-term model signals and fundamental screens.

Meyka AI forecast and price targets

Meyka AI’s forecast model projects a monthly target of C$0.020 and a 12-month model target of C$0.022, compared with the current C$0.01, implying an upside of 100.00% and 120.00% respectively. Practical analyst scenarios: conservative target C$0.015, base-case C$0.022, optimistic C$0.030. Forecasts are model-based projections and not guarantees.

Final Thoughts

XCX.CN stock’s 100.00% intraday jump to C$0.01 on CNQ on 03 Mar 2026 is a headline move driven by thin liquidity and microcap dynamics rather than clear operational news. The company carries weak fundamentals: EPS -0.03, negative book value per share, and a small market cap of C$516,554.00. Meyka AI assigns a proprietary grade of B (64.90/100) HOLD, reflecting model signals and comparative factors, while an independent company rating flags D+ Strong Sell fundamentals. For active traders, short-term setups can offer momentum trades, but longer-term investors face elevated liquidity and solvency risks. Meyka AI’s forecast model projects a 12-month target near C$0.022 (implied upside 120.00% from C$0.01). Forecasts are model-based projections and not guarantees; confirm filings and watch volume before entering positions. For more details see the company site Greenrise Global and Meyka stock page for XCX.CN.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.